Biometrics & Data Sciences Page
Tailored biometrics capabilities that cover the full drug development continuum (pre-clinical through NDA/BLA).
Drug Development Services Page
Tap into knowledge of our experts who have thousands of years of combined experience across drug development.
Modeling and Simulation Services Page
Accelerate drug development with customized biosimulation to predict efficacy, safety, and optimal dosing strategies.
Biosimulation Software Page
Biosimulation SoftwareEmpirical and mechanistic modeling solutions to support all phases of drug developmentContact us Our biosimulation software suite Biosimulation is quantitative drug development that powers decision making. Modeling and simulation...Data Science Page
Data Science SoftwareEnhance workflows and extract the full value of your dataContact us Solutions for data scientists Data is the lifeblood of drug of development. Certara's software solutions enable companies...
Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease Blog Post
RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed help streamlining the process of getting into Phase 3 clinical trials. RHB-204 combines three well-known...
What is a Global Risk Mitigation Plan & how can you use it to ensure a successful drug launch? Blog Post
A Global Risk Mitigation Plan (GRMP) is a critical step in drug development as it helps sponsors identify and address potential Market Access, Pricing & HEOR (health economics outcomes research)…
FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers Blog Post
2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus. Reprinted with permission from Applied Clinical Trials. Applied Clinical Trials is a copyrighted publication…
SEND Dataset Quality Control: Best Practices & Recommendations Blog Post
In this blog, Senior Product Management Director Peggy Zorn explores best practices & recommendations for SEND dataset review & visualizations.
